Importer of Controlled Substances; Notice of Application; Cambrex Charles City, Inc., 64013-64014 [2013-25062]

Download as PDF 64013 Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices Dated: October 22, 2013. Jerri Murray, Department Clearance Officer, PRA, U.S. Department of Justice. —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. [FR Doc. 2013–25161 Filed 10–24–13; 8:45 am] BILLING CODE 4410–18–P DEPARTMENT OF JUSTICE [OMB Number 1121—NEW] Agency Information Collection Activities; Proposed Collection; Comments Requested: Geospatial Capabilities Survey emcdonald on DSK67QTVN1PROD with NOTICES ACTION: Overview of This Information Collection 30-day Notice. The Department of Justice (DOJ), National Institute of Justice (NIJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 78, Number 156, page 49288, on August 13, 2013, allowing for a 60-day comment period. The purpose of this notice is to allow an additional 30 days for public comment until November 25, 2013 This process is conducted in accordance with 5 CFR 1320.10. Written comments concerning this information collection should be sent to the Office of Information and Regulatory Affairs, Office of Management and Budget, Attn: DOJ Desk Officer. The best way to ensure your comments are received is to email them to oira_ submission@omb.eop.gov or fax them to 202–395–7285. All comments should reference the 8 digit OMB number for the collection or the title of the collection. If you have questions concerning the collection, please call Joel Hunt at 202–616–8111. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; VerDate Mar<15>2010 17:55 Oct 24, 2013 Jkt 232001 (1) Type of Information Collection: Establishment survey and initial approval of collection. (2) Title of Form/Collection: Geospatial Capabilities Survey. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: None. National Institute of Justice, Office of Justice Programs, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Law enforcement agencies with 100 or more sworn officers. These law enforcement agencies include police departments, sheriff agencies, and state police agencies. This collection is the only effort that provides an ability to determine, in detail, the geospatial tools, techniques, and practices in use currently at large law enforcement agencies. The results of the survey will help NIJ determine how best it can meet the needs and enhance the effectiveness of geospatial capabilities among crime analysts in large police departments through future technology development grants. There is little data on the specific geospatial capabilities of law enforcement agencies and hence little data on which to base technology grant decisions to enhance crime analysis tools and techniques. This survey will update the information gathered in the Use of Computerized Crime Mapping Survey conducted by NIJ in 1997, the last survey on use of computerized crime analysis tools by NIJ and establish the basis for future technology development funding. This collection will also enable Federal, State, and local law enforcement agencies; legislators; researchers; and government agencies to understand the depth, range, and scope of geospatial capabilities currently in use at large law enforcement agencies and develop approaches to extend and enhance these capabilities towards improving policing strategies and public safety through crime solving and prevention. PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The survey will invite all of the 907 law enforcement agencies with 100 or more sworn officers to participate in the survey. The law enforcement agencies will select the personnel most fitting to their organization to provide the responses. The survey is estimated to take one hour to complete. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 907 total burden hours associated with this collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Room 3W– 1407–B, Washington, DC 20530. Dated: October 22, 2013. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2013–25160 Filed 10–24–13; 8:45 am] BILLING CODE 4410–18–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Cambrex Charles City, Inc. Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on July 24, 2013, Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616–3466, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances: Drug 4-Anilino-N-phenethyl-4-piperidine (8333). Phenylacetone (8501) .................. Cocaine (9041) ............................. Opium, raw (9600) ....................... Poppy Straw Concentrate (9670) Schedule II II II II II The company plans to import the listed controlled substances for internal use, and to manufacture bulk intermediates for sale to its customers. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture E:\FR\FM\25OCN1.SGM 25OCN1 64014 Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices such basic classes of controlled substances listed in schedules I or II, which fall under the authority of section 1002(a)(2)(B) of the Act [21 U.S.C. 952(a)(2)(B)] may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than November 25, 2013. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745, all applicants for registration to import a basic class of any controlled substance in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: September 27, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–25062 Filed 10–24–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE emcdonald on DSK67QTVN1PROD with NOTICES Importer of Controlled Substances, Notice of Application, Wildlife Laboratories, Inc. Schedule VerDate Mar<15>2010 17:55 Oct 24, 2013 I Jkt 232001 Etorphine HCl (9059) ................... II The company plans to import the listed controlled substances for sale to its customers. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedule I or II, which fall under the authority of section 1002(a)(2)(B) of the Act [21 U.S.C. 952(a)(2)(B)] may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODW), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than November 25, 2013. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745–46, all applicants for registration to import a basic class of any controlled substance in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. [FR Doc. 2013–25077 Filed 10–24–13; 8:45 am] Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on August 23, 2013, Wildlife Laboratories, Inc., 1230 Wash Street, Suite D, Windsor, Colorado 80550, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances: Etorphine (except HCl) (9056) ..... Schedule Dated: October 16, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Drug Enforcement Administration Drug Drug BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Penick Corporation This is notice that on February 28, 2013, Penick Corporation, 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances: Drug Coca Leaves (9040) ..................... Opium, raw (9600) ....................... Poppy Straw (9650) ..................... Poppy Straw Concentrate (9670) Schedule II II II II The company plans to import the listed controlled substances to manufacture bulk controlled substance intermediates for sale to its customers. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745, all applicants for registration to import a basic class of any controlled substance in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: October 17, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–25064 Filed 10–24–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; United States Pharmacopeial Convention Pursuant to Title 21 Code of Federal Regulations 1301.34 (a), this is notice that on July 31, 2013, United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of Noroxymorphone (9668), a basic class of controlled substance listed in schedule II. The company plans to import reference standards for sale to researchers and analytical labs. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic class of controlled substance listed in schedules I and II, which fall E:\FR\FM\25OCN1.SGM 25OCN1

Agencies

[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Pages 64013-64014]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25062]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application; Cambrex 
Charles City, Inc.

    Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this 
is notice that on July 24, 2013, Cambrex Charles City, Inc., 1205 11th 
Street, Charles City, Iowa 50616-3466, made application by renewal to 
the Drug Enforcement Administration (DEA) for registration as an 
importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine (8333)..  II
Phenylacetone (8501).......................  II
Cocaine (9041).............................  II
Opium, raw (9600)..........................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
internal use, and to manufacture bulk intermediates for sale to its 
customers.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (2007).
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture

[[Page 64014]]

such basic classes of controlled substances listed in schedules I or 
II, which fall under the authority of section 1002(a)(2)(B) of the Act 
[21 U.S.C. 952(a)(2)(B)] may, in the circumstances set forth in 21 
U.S.C. 958(i), file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than November 25, 2013.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, 40 FR 43745, all applicants for 
registration to import a basic class of any controlled substance in 
schedules I or II are, and will continue to be, required to demonstrate 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, that the requirements for such 
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 
1301.34(b), (c), (d), (e), and (f) are satisfied.

     Dated: September 27, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-25062 Filed 10-24-13; 8:45 am]
BILLING CODE 4410-09-P